Double Your Year-End Gift – Help Create a Future Without CMT!
…walker behind. Zolana, diagnosed at 7, dreams of becoming an artist and supports CMTA’s groundbreaking research to make a world free of CMT pain possible. By making your year-end donation…
CMTA-STAR Alliance Partner Actio Biosciences Receives FDA Orphan Drug Designation and Rare Pediatric Disease Designation for Their Treatment in Development for CMT2C
…designation (RPDD) designation from the FDA for ABS-0871, a TRPV4 inhibitor for treating CMT2C. This achievement represents a crucial step forward for CMT2C patients and the CMT community. “We are…
Jonah Berger, CMTA Youth Programs Manager
How to Talk About CMT Jonah Berger It is one thing to travel through this life with the unstable feet and uncertain balance of CMT. It is another thing altogether…
Faces of CMT Photography Competition
…living with CMT and strategies to overcome them.” This is an international competition open to everyone! Whether you’re living with, or alongside CMT, this is an opportunity to share your…
CMTA Grassroots Events
At the CMTA, our vision is a world without CMT. Our mission is to support the development of new drugs to treat CMT, to improve the quality of life for…
CMTA Unveils Updated Logo
…20 pharmaceutical and biotechnology partners, the world’s top CMT scientists collaborating through STAR, and a community powering our efforts, the CMTA is leading the way to a world without CMT….
Disability for CMT Peripheral Neuropathy: VA & Social Security
How likely are people with CMT to get Social Security disability benefits the first time they apply? Many people believe that it is very difficult to get disability benefits from…
Breakthrough in CMT1A Research: Community Efforts Drive Success of Dental Stem Cell Model
…for future drug screening and treatment development beyond CMT1A, including CMT1E, HNPP, CMTX1 (aka CMT1X, CMTX), CMT2A, CMT2C, CMT2T, and CMT4A—the additional subtypes from which donations were received. Register With…
CMTA and Pharnext Enter Biomarker Research Collaboration
…About CMTA The CMTA is aggressively leading the fight to fund the development of treatments and, ultimately, a cure for CMT. Through its Strategy to Accelerate Research (STAR), the CMTA…
CMT2S Breakthrough
…marks a significant step forward for community members who have CMT2S. CMT2S is a very rare and often debilitating autosomal recessive type of CMT. A potential treatment for CMT2S, Vanda’s…